EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neuroprotective effects of Interleukin-1 receptor antagonism after cardiac arrest: an experimental rat study

Bilal Arslan iD, Fatma Ayaz Yalınkılıç iD, Adnan Erseçkin iD, Burhan Beger iD, Bilal Acar iD, Utku Batu iD, Mehmet Mehdi Oğuz iD, Abdulaziz Yalınkılıç iD, Orhan Beger iD, Mehmet Zeki Erdem iD, Halit Demir iD

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-05 · 399 (8) · 12573-12584

DOI: 10.1007/s00210-026-05135-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 16.03.2026. Verfasst von Bilal Arslan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Van Yüzüncü Yıl University Faculty of Medicine, Van, Turkey. arslanbilal_351@hotmail.com. Hauptthemen laut MEDLINE: Neuroprotective Agents, Interleukin 1 Receptor Antagonist Protein, Heart Arrest, Receptors, Interleukin-1. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to investigate the histopathological and biochemical neuroprotective effects of IL-1 receptor antagonist (anakinra) administration in an asphyxia-induced cardiac arrest model. A total of 24 Wistar albino rats were randomized into three groups: control, sham (cardiac arrest + saline), and anakinra (cardiac arrest + 50 mg/kg anakinra). Brain tissues were evaluated using a six-parameter semi-quantitative histopathological scoring system, and the composite damage score (CDS) was calculated (0–12). Levels of antioxidant and oxidative markers SOD, CAT, GSH, and MDA were analyzed spectrophotometrically. In the anakinra-treated group, neuronal degeneration, gliosis, and neuropil edema levels were significantly lower compared to the sham group ( p < 0.01 for all). Although vascular congestion and perivascular edema were observed to be lower in the anakinra group, this reduction was not statistically significant in score analyses compared to the sham group ( p > 0.05). No significant difference was found between the groups in terms of PMNL infiltration. In biochemical analyses, SOD, CAT, and GSH levels were found to be significantly higher in the anakinra group compared to both the sham and control groups ( p < 0.001), while MDA levels were significantly lower ( p < 0.001). These findings indicate that anakinra reduces oxidative stress and significantly alleviates neurohistopathological damage in the experimental model. Anakinra administration significantly reduced short-term hypoxic-ischemic brain damage following cardiac arrest, both in terms of histopathological and oxidative stress parameters. The findings suggest that targeting the IL-1-mediated inflammatory response could be an important neuroprotective approach; however, further studies are needed regarding dose, timing of administration, and long-term neurological function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroprotective AgentsInterleukin 1 Receptor Antagonist ProteinHeart ArrestReceptors, Interleukin-1AnimalsRats, WistarMaleOxidative StressRatsBrainDisease Models, AnimalAntioxidantsGlutathione

Stichwörter der Autor:innen

AnakinraCardiac arrestExperimental modelIL-1 receptor antagonistNeuroinflammationNeuroprotectionOxidative stress

Substanzen

Neuroprotective AgentsInterleukin 1 Receptor Antagonist ProteinReceptors, Interleukin-1AntioxidantsGlutathione

Autor:innen und Institutionen

  • Department of Pediatrics, Van Yüzüncü Yıl University Faculty of Medicine, Van, Turkey. arslanbilal_351@hotmail.com.
  • Department of Pathology, Van Yüzüncü Yıl University Faculty of Medicine, Van, Turkey.
  • Department of Pediatrics, Van Yüzüncü Yıl University Faculty of Medicine, Van, Turkey.
  • Department of Pediatric Surgery, Van Yüzüncü Yıl University Faculty of Medicine, Van, Turkey.
  • Department of Pediatrics, Ağrı Private Lena Hospital, Ağrı, Turkey.
  • Department of Pediatrics, Van Regional Training and Research Hospital, Van, Turkey.

ORCID-Profile: Bilal Arslan, Fatma Ayaz Yalınkılıç, Adnan Erseçkin, Burhan Beger, Bilal Acar, Utku Batu, Mehmet Mehdi Oğuz, Abdulaziz Yalınkılıç, Orhan Beger, Mehmet Zeki Erdem, Halit Demir

Zitieren

APA

Arslan, B., Yalınkılıç, F. A., Erseçkin, A., Beger, B., Acar, B., Batu, U., Oğuz, M. M., Yalınkılıç, A., Beger, O., Erdem, M. Z., & Demir, H. (2026). Neuroprotective effects of Interleukin-1 receptor antagonism after cardiac arrest: an experimental rat study. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(8), 12573-12584. https://doi.org/10.1007/s00210-026-05135-w

Vancouver

Arslan B, Yalınkılıç FA, Erseçkin A, Beger B, Acar B, Batu U, et al. Neuroprotective effects of Interleukin-1 receptor antagonism after cardiac arrest: an experimental rat study. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(8):12573-12584. doi:10.1007/s00210-026-05135-w

BibTeX
@article{Arslan2026,
  author = {Arslan, Bilal and Yalınkılıç, Fatma Ayaz and Erseçkin, Adnan and Beger, Burhan and Acar, Bilal and Batu, Utku and Oğuz, Mehmet Mehdi and Yalınkılıç, Abdulaziz and Beger, Orhan and Erdem, Mehmet Zeki and Demir, Halit},
  title = {Neuroprotective effects of Interleukin-1 receptor antagonism after cardiac arrest: an experimental rat study},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  volume = {399},
  number = {8},
  pages = {12573--12584},
  doi = {10.1007/s00210-026-05135-w}
}
Kostenlos starten →